Healthcare
6 articles
Medicare offers $50 monthly GLP-1 access amid obesity drug competition
Starting July 1, 2026, eligible Medicare beneficiaries will pay just $50 a month for certain GLP-1 obesity drugs.
Legend Biotech stock surges on strong Q1 CAR T-cell therapy results
Legend Biotech's stock recently jumped 42% following new data, propelled by early clinical successes in difficult-to-treat cancers and robust sales of its existing CAR-T therapy, CARVYKTI, according t
General Catalyst Acquires Summa Health for $515M, Boosting Tech Initiatives
After posting a $43.5 million operating loss in 2023, Summa Health is shedding $850 million in debt, transitioning to a for-profit entity under General Catalyst's ownership. This move sees General Cat
Bristol Myers Squibb shows strong multiple myeloma data
In a significant development for multiple myeloma patients, Bristol Myers Squibb's mezigdomide triplet demonstrated a median progression-free survival of 18 months, more than doubling the 8.
Congress cuts $1 trillion from healthcare, raising costs for millions
In January 2026, 20 million Americans saw their healthcare insurance costs jump by $1,000 a year.
Merck Halts Parkinson's Drug Program After Phase 3 Setback
Merck's Parkinson's drug, preladenant, was discontinued in 2026 after Phase 3 trials showed it was no more effective than a placebo.